pharma · Chronic Inflammatory Demyelinating Polyneuropathy · Multifocal Motor Neuropathy · DNTH
Dianthus Therapeutics, Inc
Dianthus Therapeutics, Inc. /DE/
Dianthus Therapeutics, Inc patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- New York City, USA
- Employees
- 111
- Programs
- 6
- Drugs
- 12
- Patents
- 2
Dianthus Therapeutics, Inc patents
2 pharmaceutical patents indexed for Dianthus Therapeutics, Inc. 0 expire within 24 months.
Dianthus Therapeutics, Inc has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Dianthus Therapeutics, Inc have?
2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Dianthus Therapeutics, Inc patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.